Pharmacist's Letter

Current Issue

April 2021 Issue

Address New Questions About COVID-19 Vaccines

You'll get more questions about COVID-19 vaccinations...

Resources

FAQ: Communicating About COVID-19 Vaccination
Chart: COVID-19 Vaccines

Identify Candidates for COVID-19 Monoclonal Antibodies

Bamlanivimab/etesevimab will be the third monoclonal antibody option authorized to treat OUTpatients with COVID-19...

Put Inhaled and Oral COVID-19 Treatments in Perspective

You'll be asked whether OUTpatients with COVID-19 should be treated with inhaled corticosteroids, colchicine, or fluvoxamine...

Think of Verquvo as a "Niche" Med for Heart Failure

Reps will tout Verquvo (vericiguat) as a new once-daily add-on for worsening heart failure with reduced ejection fraction (HFrEF)...

GO TO FULL ISSUE

COVID-19

COVID-19 vaccine

Treatments of Interest for COVID-19

COVID-19 Point-of-Care Testing

COVID Pharmacotherapy FAQs

BROWSE MORE RESOURCES

CE & Training

Prevention and Treatment of Type 2 Diabetes

Naloxone for Opioid Rescue Therapy

Depression Treatment Options

MORE CE COURSES

Popular Charts

Med Updates

Verquvo
vericiguat
A guanylate cyclase stimulator for patients with symptomatic chronic heart failure and ejection fraction <45%

Cabenuva
cabotegravir/rilpivirine
A co-packaged injectable integrase strand transfer inhibitor and non-nucleoside reverse transcriptase inhibitor for HIV-1 infection

Winlevi
clascoterone
An androgen receptor inhibitor topical cream for acne

MORE MED UPDATES